CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Biopharmia is developing the Accordion bioreactor for efficient microalgae cultivation, aiming to enhance Europe's competitiveness in the microalgae market. This technology promises lower production costs and higher quality, addressing the growing demand for sustainable raw materials in various industries.
Access to vital raw ingredients for food/feed production is an increasing challenge in several industries.
Biopharmia is a Norwegian company focusing on cultivation of microalgae through its development of a proprietary bioreactor.
Through years of expertise and collaborations with experts in the field of microalgae growth, Biopharmia have developed and patented the Accordion bioreactor, a proven and efficient platform for industrial scale production of high quality microalgae, at lower energy a…
BIOPHARMIA AS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
